NASDAQ:AUPH | Cash Flow Statement | Aurinia Pharmaceuticals Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$37.41M
2026-03-31$34.36M$4.82M$32.56M-$18.08M$36.17M-$53.69M
2025-12-31$210.79M$4.86M$45.67M-$36.76M$0.00-$1.89M
2025-09-30$31.55M
2025-06-30$21.51M
2025-03-31$23.34M$4.86M$1.3M$31.03M$46.92M-$49.34M
2024-12-31$1.43M$4.86M$30.11M$39.22M$21.8M-$23.05M
2024-09-30$14.35M
2024-06-30$722,000.00
2024-03-31-$10.75M$4.85M-$18.6M$49.23M$12.3M-$15.05M
2023-12-31-$26.88M$14.31M-$6.26M$0.00-$5.58M
2023-09-30-$13.45M
2023-06-30-$11.49M
2023-03-31-$26.21M-$31.67M$24.86M$0.00$1.64M
2022-12-31-$26.05M$10.45M-$3.02M$688,000.00
2022-09-30-$8.99M
2022-06-30-$35.52M
2022-03-31-$37.63M-$46.75M-$53.02M$405,000.00
2021-12-31-$33.32M-$25.92M-$5.49M$205.72M
2021-09-30-$50.26M
2021-06-30-$47.01M
2021-03-31-$50.38M-$53.54M-$67.25M$5.03M
2020-12-31-$8.07M$3.2M$19.15M$1.24M
2020-09-30-$42.13M
2020-06-30-$26.54M
2020-03-31-$25.93M-$22.61M-$12.13M$2.92M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$287.2M$19.45M$135.66M-$32.77M$98.16M-$106.11M
2024-12-31$5.75M$19.45M$44.39M$39.26M$40.24M-$49.09M
2023-12-31-$78.02M$11.65M-$33.46M-$6.71M$0.00-$5.13M
2022-12-31-$108.18M$2.71M-$79.53M-$60.63M$0.00$2.43M
2021-12-31-$180.97M$2.76M-$157.69M-$103.87M$221.11M
2020-12-31-$102.68M$1.37M-$69.86M-$158.19M$194.38M
2019-12-31-$88.39M-$63.59M$7.78M$243.85M
2018-12-31-$53.08M-$51.61M-$65,000.00$4.01M